TP53 transcription factor for the NEDD9/HEF1/Cas-L gene: potential targets in Non-Small Cell Lung Cancer treatment

Autor: Bénédicte Rousseau, Catherine Jacquot, Christos Roussakis, Marine Malleter, Tifenn Boutard, Vehary Sakanyan, Christophe Tomasoni, Julie Le Palabe

Publikováno v: Scientific Reports
Scientific Reports, Nature Publishing Group, 2015, 5 (1), pp.10356. ⟨10.1038/srep10356⟩
Scientific Reports, 2015, 5 (1), pp.10356. ⟨10.1038/srep10356⟩

Lung cancer is a serious public health problem. Although there has been significant progress in chemotherapy, non-small cell lung cancer is still resistant to current treatments, primarily because of the slow rate of cell development. It is thus impo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2da94084f3235efd6ca8d578c803d05
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01165439/document